Showing results (941-950 of 2,896) with videos related to

Sort By:
Pageof 290
JACC. Cardiovascular Interventions|January 21, 2022
Cusp Symmetry and Coronary Ostial Eccentricity and its Impact on Coronary Access Following TAVRXi Wang, Ole De Backer, Gintautas Bieliauskas, et al.
JACC. Cardiovascular Interventions|January 21, 2022
Improved 3-Year Cardiac Survival After IVUS-Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized TrialsSung-Jin Hong, Jun-Jie Zhang, Gary S Mintz, et al.
JACC. Cardiovascular Interventions|February 28, 2021
Impact of Coronary Artery Tortuosity on Outcomes Following Stenting: A Pooled Analysis From 6 TrialsMaayan Konigstein, Ori Ben-Yehuda, Björn Redfors, et al.
JACC. Cardiovascular Interventions|February 28, 2021
Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient SampleAyman Elbadawi, Islam Y Elgendy, Marwan Saad, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive ManagementFelice Gragnano, Mattia Branca, Enrico Frigoli, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-AnalysisMarco Valgimigli, Roxana Mehran, Anna Franzone, et al.
JACC. Cardiovascular Interventions|February 14, 2021
Online Quantitative Aortographic Assessment of Aortic Regurgitation After TAVR: Results of the OVAL StudyRodrigo Modolo, Martijn van Mourik, Abdelhak El Bouziani, et al.
JACC. Cardiovascular Interventions|January 21, 2017
Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV TrialKoen Teeuwen, René J van der Schaaf, Tom Adriaenssens, et al.
JACC. Cardiovascular Interventions|April 22, 2017
Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III TrialSuzanne J Baron, Yang Lei, Khaja Chinnakondepalli, et al.
JACC. Cardiovascular Interventions|September 2, 2019
Primary and Secondary Vascular Access Site Complications Associated With Percutaneous Coronary Intervention: Insights From the BMC2 RegistryDavid Kopin, Milan Seth, Devraj Sukul, et al.
Pageof 290